<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137917">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01976481</url>
  </required_header>
  <id_info>
    <org_study_id>sunbed study</org_study_id>
    <nct_id>NCT01976481</nct_id>
  </id_info>
  <brief_title>Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27</brief_title>
  <official_title>Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study aims to clarify the impact of the use of a standard sunbed according to new EU
      guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan
      to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new
      recommendations for the exposure plan for different skin types according to EN 60335-2-27.

      The use of a sunbed will be compared to a control group not using a sunbed in the
      observation period.

        -  Trial with medical device
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will compare to baseline changes in serum vitamin D and health-related quality of life
      using a control group and an intervention group.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Determination of number of patients with a relevant elevation of serum 25-hydroxyvitamin D levels of =10ug/L from the baseline</measure>
    <time_frame>six months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Skin Toxicity</condition>
  <arm_group>
    <arm_group_label>Sunbed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sunbed exposure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sunbed exposure</intervention_name>
    <description>exposure to sunbed ultraviolet radiation</description>
    <arm_group_label>Sunbed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: Probands intending to use a commercial sunbed :

          1. Age 18 years or older

          2. Regular use of commercial sunbeds

          3. Oral and written informed consent

        Exclusion criteria: 1. Skin type I according to Fitzpatrick according to EU guideline EN
        60335-2-27 2. Sunbed use within the last three months 3. Use of vitamin D supplements or
        multivitamin supplements 4. Any medical condition which renders them unfit for sunbed use
        in the judgment of the investigator 5. Inability to provide oral and written consent to
        participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guenther Hofbauer, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Dermatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guenther Hofbauer, Prof MD</last_name>
    <email>hofbauer@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Dermatology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 29, 2013</lastchanged_date>
  <firstreceived_date>October 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
